Jilin Qing

Nanning, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Establishment of a rapid and highly sensitive direct-RAA-RDB detection platform: application in non-deletion α-thalassemia.

Establishment of a rapid and highly sensitive direct-RAA-RDB detection platform: application in non-deletion α-thalassemia.

Journal: Frontiers in molecular biosciences
Published: March 27, 2026

Integrating isothermal amplification with magnetic flocculation and DNA-guided PfAgo for SARS-CoV-2 detection.

Integrating isothermal amplification with magnetic flocculation and DNA-guided PfAgo for SARS-CoV-2 detection.

Journal: Frontiers in microbiology
Published: January 21, 2026

Novel Double Heterozygosity: HBA2: c.70G > A (Hb Chad)/HBB: c.-78A > G and Novel Compound Heterozygosity: HBA2: c.70G > A (Hb Chad)/HBA1: c.84G > T (Hb Hekinan II) Hemoglobinopathy in a Chinese Family.

Novel Double Heterozygosity: HBA2: c.70G > A (Hb Chad)/HBB: c.-78A > G and Novel Compound Heterozygosity: HBA2: c.70G > A (Hb Chad)/HBA1: c.84G > T (Hb Hekinan II) Hemoglobinopathy in a Chinese Family.

Journal: Hemoglobin
Published: July 20, 2025

A direct multiplex isothermal amplification-reverse dot blot hybridization system for β-thalassemia diagnosis.

A direct multiplex isothermal amplification-reverse dot blot hybridization system for β-thalassemia diagnosis.

Journal: Annals of hematology
Published: July 04, 2025

Recombinase-aided amplification technology: A comprehensive review of innovations and multi-technology integration for rapid infectious disease diagnosis.

Recombinase-aided amplification technology: A comprehensive review of innovations and multi-technology integration for rapid infectious disease diagnosis.

Journal: Analytica chimica acta
Published: June 26, 2025

Advances in the application of CRISPR technology in pathogen detection: amplification-based and amplification-free strategies.

Advances in the application of CRISPR technology in pathogen detection: amplification-based and amplification-free strategies.

Journal: Frontiers in cellular and infection microbiology
Published: June 12, 2025

A sample-in- result -out microfluidic system for β-thalassemia diagnostics via direct whole blood PCR-reverse dot blot.

A sample-in- result -out microfluidic system for β-thalassemia diagnostics via direct whole blood PCR-reverse dot blot.

Journal: Clinica chimica acta; international journal of clinical chemistry
Published: January 27, 2025

Up-regulation of blood-circulating TIM-4-expressing monocytes and potential diagnostic biomarker sTIM-4 in primary liver cancer.

Up-regulation of blood-circulating TIM-4-expressing monocytes and potential diagnostic biomarker sTIM-4 in primary liver cancer.

Journal: Scientific reports
Published: January 15, 2025

Application of recombinase polymerase amplification with lateral flow assay to pathogen point-of-care diagnosis.

Application of recombinase polymerase amplification with lateral flow assay to pathogen point-of-care diagnosis.

Journal: Frontiers in cellular and infection microbiology
Published: August 04, 2024

Role of TIM-1 in the development and treatment of tumours.

Role of TIM-1 in the development and treatment of tumours.

Journal: Frontiers in cell and developmental biology
Published: October 06, 2023

TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.

TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.

Journal: BMC cancer
Published: November 03, 2021

TIM-3 Participates in the Invasion and Metastasis of Nasopharyngeal Carcinoma via SMAD7/SMAD2/SNAIL1 Axis-Mediated Epithelial-Mesenchymal Transition.

TIM-3 Participates in the Invasion and Metastasis of Nasopharyngeal Carcinoma via SMAD7/SMAD2/SNAIL1 Axis-Mediated Epithelial-Mesenchymal Transition.

Journal: OncoTargets and therapy
Published: November 04, 2019
Showing 1-12 of 15

Last Updated: 09/26/2026